Avepoint Research Development vs Non Operating Income Net Other Analysis

AVPT Stock

USD 18.12 0.10 0.55%

Avepoint financial indicator trend analysis is way more than just evaluating Avepoint prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Avepoint is a good investment. Please check the relationship between Avepoint Research Development and its Non Operating Income Net Other accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avepoint. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Avepoint Stock please use our How to Invest in Avepoint guide.

Research Development vs Non Operating Income Net Other

Research Development vs Non Operating Income Net Other Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Avepoint Research Development account and Non Operating Income Net Other. At this time, the significance of the direction appears to have strong relationship.

The correlation between Avepoint's Research Development and Non Operating Income Net Other is 0.68. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Non Operating Income Net Other in the same time period over historical financial statements of Avepoint, assuming nothing else is changed. The correlation between historical values of Avepoint's Research Development and Non Operating Income Net Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Avepoint are associated (or correlated) with its Non Operating Income Net Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Operating Income Net Other has no effect on the direction of Research Development i.e., Avepoint's Research Development and Non Operating Income Net Other go up and down completely randomly.

Correlation Coefficient

0.68

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Research Development

Non Operating Income Net Other

Most indicators from Avepoint's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Avepoint current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avepoint. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Avepoint Stock please use our How to Invest in Avepoint guide.At this time, Avepoint's Tax Provision is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 1.2 B in 2024, whereas Selling General Administrative is likely to drop slightly above 54.3 M in 2024.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	1.2M	3.5M	4.7M	2.5M
Interest Income	102K	72K	26K	47.5K

Depreciation And Amortization Interest Income

Avepoint fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Retained Earnings Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Capital Surpluse	Inventory	Other Current Assets	Other Stockholder Equity
Total Assets		0.19	0.27	0.48	-0.93	0.01	0.55	0.41	-0.4	-0.23	0.59	0.42	0.03	0.16	-0.32	0.42	0.46	-0.32	-0.04	0.71	0.71	-0.74	0.07	0.01	0.57	0.4
Other Current Liab	0.19		0.99	-0.74	-0.46	0.98	0.78	0.94	-0.93	-0.98	0.79	0.94	-0.96	1.0	-0.2	0.94	0.91	-0.58	-0.98	0.82	-0.47	0.08	0.98	0.97	0.91	0.97
Total Current Liabilities	0.27	0.99		-0.69	-0.52	0.95	0.83	0.97	-0.93	-0.98	0.78	0.94	-0.92	0.99	-0.27	0.94	0.95	-0.62	-0.95	0.86	-0.37	0.07	0.96	0.94	0.94	0.97
Total Stockholder Equity	0.48	-0.74	-0.69		-0.18	-0.82	-0.35	-0.58	0.54	0.73	-0.25	-0.52	0.84	-0.77	0.15	-0.52	-0.52	0.47	0.82	-0.23	0.83	-0.59	-0.77	-0.83	-0.41	-0.56
Other Liab	-0.93	-0.46	-0.52	-0.18		-0.31	-0.68	-0.61	0.67	0.52	-0.79	-0.66	0.28	-0.43	0.36	-0.66	-0.65	0.55	0.34	-0.86	-0.45	0.72	-0.32	-0.32	-0.76	-0.64
Net Tangible Assets	0.01	0.98	0.95	-0.82	-0.31		0.65	0.86	-0.9	-0.96	0.73	0.9	-0.99	0.97	-0.1	0.9	0.81	-0.52	-1.0	0.7	-0.62	0.16	0.99	1.0	0.82	0.92
Property Plant And Equipment Net	0.55	0.78	0.83	-0.35	-0.68	0.65		0.89	-0.73	-0.77	0.65	0.76	-0.6	0.77	-0.29	0.76	0.9	-0.53	-0.67	0.89	0.01	-0.07	0.7	0.63	0.88	0.81
Current Deferred Revenue	0.41	0.94	0.97	-0.58	-0.61	0.86	0.89		-0.88	-0.93	0.75	0.89	-0.82	0.95	-0.43	0.9	1.0	-0.69	-0.86	0.89	-0.18	0.04	0.89	0.85	0.96	0.94
Net Debt	-0.4	-0.93	-0.93	0.54	0.67	-0.9	-0.73	-0.88		0.95	-0.95	-0.99	0.89	-0.91	0.19	-0.99	-0.86	0.62	0.91	-0.89	0.32	0.26	-0.88	-0.91	-0.94	-0.98
Retained Earnings	-0.23	-0.98	-0.98	0.73	0.52	-0.96	-0.77	-0.93	0.95		-0.8	-0.94	0.95	-0.98	0.3	-0.94	-0.91	0.71	0.97	-0.82	0.44	-0.01	-0.93	-0.96	-0.9	-0.96
Accounts Payable	0.59	0.79	0.78	-0.25	-0.79	0.73	0.65	0.75	-0.95	-0.8		0.95	-0.73	0.74	-0.06	0.94	0.73	-0.47	-0.75	0.91	-0.13	-0.54	0.73	0.74	0.89	0.91
Cash	0.42	0.94	0.94	-0.52	-0.66	0.9	0.76	0.89	-0.99	-0.94	0.95		-0.89	0.92	-0.12	1.0	0.87	-0.54	-0.91	0.91	-0.31	-0.24	0.91	0.9	0.95	0.99
Non Current Assets Total	0.03	-0.96	-0.92	0.84	0.28	-0.99	-0.6	-0.82	0.89	0.95	-0.73	-0.89		-0.95	0.08	-0.89	-0.77	0.53	0.99	-0.66	0.67	-0.15	-0.96	-1.0	-0.78	-0.9
Non Currrent Assets Other	0.16	1.0	0.99	-0.77	-0.43	0.97	0.77	0.95	-0.91	-0.98	0.74	0.92	-0.95		-0.27	0.92	0.92	-0.62	-0.97	0.79	-0.46	0.15	0.98	0.97	0.9	0.95
Other Assets	-0.32	-0.2	-0.27	0.15	0.36	-0.1	-0.29	-0.43	0.19	0.3	-0.06	-0.12	0.08	-0.27		-0.13	-0.49	0.82	0.09	-0.24	-0.38	-0.12	-0.08	-0.12	-0.3	-0.17
Cash And Short Term Investments	0.42	0.94	0.94	-0.52	-0.66	0.9	0.76	0.9	-0.99	-0.94	0.94	1.0	-0.89	0.92	-0.13		0.87	-0.54	-0.91	0.92	-0.31	-0.24	0.91	0.9	0.95	0.99
Net Receivables	0.46	0.91	0.95	-0.52	-0.65	0.81	0.9	1.0	-0.86	-0.91	0.73	0.87	-0.77	0.92	-0.49	0.87		-0.71	-0.81	0.9	-0.09	0.02	0.85	0.8	0.96	0.91
Common Stock Total Equity	-0.32	-0.58	-0.62	0.47	0.55	-0.52	-0.53	-0.69	0.62	0.71	-0.47	-0.54	0.53	-0.62	0.82	-0.54	-0.71		0.54	-0.54	0.0	0.05	-0.44	-0.55	-0.6	-0.57
Retained Earnings Total Equity	-0.04	-0.98	-0.95	0.82	0.34	-1.0	-0.67	-0.86	0.91	0.97	-0.75	-0.91	0.99	-0.97	0.09	-0.91	-0.81	0.54		-0.72	0.62	-0.12	-0.97	-1.0	-0.82	-0.93
Common Stock Shares Outstanding	0.71	0.82	0.86	-0.23	-0.86	0.7	0.89	0.89	-0.89	-0.82	0.91	0.91	-0.66	0.79	-0.24	0.92	0.9	-0.54	-0.72		0.06	-0.39	0.74	0.69	0.98	0.92
Short Term Investments	0.71	-0.47	-0.37	0.83	-0.45	-0.62	0.01	-0.18	0.32	0.44	-0.13	-0.31	0.67	-0.46	-0.38	-0.31	-0.09	0.0	0.62	0.06		-0.47	-0.56	-0.64	-0.08	-0.31
Non Current Liabilities Total	-0.74	0.08	0.07	-0.59	0.72	0.16	-0.07	0.04	0.26	-0.01	-0.54	-0.24	-0.15	0.15	-0.12	-0.24	0.02	0.05	-0.12	-0.39	-0.47		0.18	0.13	-0.21	-0.16
Capital Surpluse	0.07	0.98	0.96	-0.77	-0.32	0.99	0.7	0.89	-0.88	-0.93	0.73	0.91	-0.96	0.98	-0.08	0.91	0.85	-0.44	-0.97	0.74	-0.56	0.18		0.97	0.85	0.93
Inventory	0.01	0.97	0.94	-0.83	-0.32	1.0	0.63	0.85	-0.91	-0.96	0.74	0.9	-1.0	0.97	-0.12	0.9	0.8	-0.55	-1.0	0.69	-0.64	0.13	0.97		0.81	0.91
Other Current Assets	0.57	0.91	0.94	-0.41	-0.76	0.82	0.88	0.96	-0.94	-0.9	0.89	0.95	-0.78	0.9	-0.3	0.95	0.96	-0.6	-0.82	0.98	-0.08	-0.21	0.85	0.81		0.97
Other Stockholder Equity	0.4	0.97	0.97	-0.56	-0.64	0.92	0.81	0.94	-0.98	-0.96	0.91	0.99	-0.9	0.95	-0.17	0.99	0.91	-0.57	-0.93	0.92	-0.31	-0.16	0.93	0.91	0.97

Click cells to compare fundamentals

Avepoint Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Avepoint Stock Analysis

When running Avepoint's price analysis, check to measure Avepoint's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avepoint is operating at the current time. Most of Avepoint's value examination focuses on studying past and present price action to predict the probability of Avepoint's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avepoint's price. Additionally, you may evaluate how the addition of Avepoint to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Avepoint Research Development vs Non Operating Income Net Other Analysis

Research Development vs Non Operating Income Net Other

Research Development vs Non Operating Income Net Other Correlation Analysis

Correlation Coefficient

Research Development

Non Operating Income Net Other

Avepoint fundamental ratios Correlations

Avepoint Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Avepoint Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Currrent Assets Other	+ 1.0	Other Current Liab
Inventory	+ 1.0	Net Tangible Assets
Net Receivables	+ 1.0	Current Deferred Revenue
Cash And Short Term Investments	+ 1.0	Cash
Total Current Liabilities	+ 0.99	Other Current Liab
Non Currrent Assets Other	+ 0.99	Total Current Liabilities

Inventory	- 1.0	Retained Earnings Total Equity
Inventory	- 1.0	Non Current Assets Total
Retained Earnings Total Equity	- 1.0	Net Tangible Assets
Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Non Current Assets Total	- 0.99	Net Tangible Assets